Reading Room Production — page 188
of 496 pages · text recovered by OCR
← p.187 p.189 → · this page in the original PDF · package
DRAFT, PRE-DECISIONAL
©
There has been a long-standing interest among RML scientists ion CoV infections
and potential for spillover from animals to humansemong RME-seientists.
©
CoV are considered to be among the likely causes of future pandemics.
©
WIV-1is a coronavirus that was isolated from bats and characterized by WIV
scientists.
©
Itis not closely related to nor a progenitor of SARS-CoV-1/2 n>» MERS-CoV.
©
WIV scientists posted the WIV-1 sequence on a public database.
©
USS. scientists used that sequence to construct a virus using standard virology
methods that they outlined in a 2016 PNASViruses article.
+
They did not get actual virus from WIV.
=
The RML scientists collaborated with the U.S. scientists (University of
North Carolina) thetwho had constructed the WIV-1 and got the virus
from them for their studies.
=
[RML scientists do not and have never collaborated directly with WIV
scientists. I
Research at RML on WIV-1
©
Because of the interest in CoV, RML scientists decided to study WIV-1 to
determine if WIV-1 had potential to spread to people and be a potential pandemic
pathogen.
=
Identifying potential pandemic critical pathogens is on essential» research
goal in preventing future pandemics.
o
WIV-1 did not grow well in the bats and the bats did not shed the virus.
o
The work was deneperformed in 2016 and published in 2018 -- well before
COVID-19 was ever identified.
Tough Q/As:
1. Did Daily Mail reach out to NIH prior to the article for comment?
No, the Daily Mail did not ask NIH to comment. Additional background, Daily Mail
rarely asks NIH to comment on upcoming articles regarding NIH.
2. Does RML fund GOF research?
The 2016 study was a natural history study of WIV-1 and there were no GOF aspects of
the study. The viruses used in the experiment were as they weere found in nature and
were not changed by the investigators. [Alll work is reviewed by
the Institutional Biosafety
Commented [NIH3]: NIAID - please confirm this
point. Are there papers that someone from RML and
WIV are co-authors?
NIH
2023-11-27 12:35:00
Commented [SS([4R3]: To OLPA: NIAID can
confirm this statement. We cannot speak to
affiliations of individual scientists prior to, or
subsequent to, their collaborations with RML. As you
are aware, other components of NIH have provided
grants directly to WIV in the past.
Selgrade, Sara (NIH/NIAID) [E]
2023-11-28 16:42:00
Committee and. as applicable, the Dual Use Research of Concern Institutional Review
Entity prior
to b
conducted.
Commented [M[5]: Not sure if you want a broader
statement here. Feel free to delete if preferred. Could
always pull language from other letters to add if
needed.
McCormick-Ell, Jessica (NIH/OD/ORS) [E]
2023-11-27 17:10:00
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/reading_room/188
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| reading_room:exh:00056 | — | attachment | 188 |
| For your awareness: materials requested for Dr. Tabak | 2023-11-29 | 186–188 |